AXSM

As of 2026-09-10, AXSM scores 36out of 100 on QNTM’s five-factor quantitative model, a low conviction reading. The score blends momentum, quality, volume, value and sentiment, then adjusts for the current macro regime. AXSM trades at $211.12, 116% above the band ceiling.

AXSM scores 36 out of 100 on QNTM's five-factor model — a low-conviction reading — at 36 the factor profile is among the weaker names in the universe. Its strongest factor is momentum at 44 (middling), where price trend and relative strength are working in its favor, followed by sentiment at 39. The weakest is quality at 33, where earnings-quality metrics lag. Among Healthcare stocks it sits in the lower 15% of Healthcare names by composite.

On valuation, AXSM is priced near the top of its recent range — the rich end on the model's valuation read. The five factors sit close together, so the composite reflects a balanced profile rather than one dominant driver. The blended composite before the macro overlay was 37. Same-sector names the model rates nearby include HALO, THC, TGTX.

This is a descriptive factor read on AXSM, recomputed each trading day and shown with its reasoning — not a recommendation to buy, hold or sell. The score reflects where AXSM sits on the model's measures today, and can change as new data arrives.

FACTOR BREAKDOWN

VALUATION RANGE

QNTM’s descriptive fair-value band for AXSM runs $64.53–$97.76. Current price $211.12 sits 116% above the band ceiling. This is valuation context, not a price target.

OTHER HEALTHCARE NAMES

QNTM provides quantitative model outputs for informational and educational purposes only. It is not investment advice and QNTM is not a registered investment adviser. Scores are rankings, not buy/sell recommendations. Data as of 2026-09-10.